市场调查报告书

输液疗法的全球市场:输液手法·输液类别·各用途·各地区的未来预测

Fluid Therapy Market - Forecast (2020 - 2025)

出版商 IndustryARC 商品编码 850084
出版日期 内容资讯 英文 106 Pages
商品交期: 2-3个工作天内
价格
输液疗法的全球市场:输液手法·输液类别·各用途·各地区的未来预测 Fluid Therapy Market - Forecast (2020 - 2025)
出版日期: 2020年03月11日内容资讯: 英文 106 Pages
简介

本报告提供全球输液疗法的市场相关分析,提供整体市场结构和背景情况,主要的推动及阻碍市场要素,加入市场的方法与难易度,各输液手法·输液类别·各用途·各地区的市场趋势预测 (今后7年份),市场竞争结构,近来的资本交易·策略展开的动向,主要企业的简介等相关调查。

第1章 输液疗法:市场概要

第2章 输液疗法市场:摘要整理

第3章 输液疗法市场

  • 比较分析
    • 产品的互相比较:前十大企业的情况
    • 前五名公司的财务分析
    • 市场规模的明细 (以金额为准):前十大企业的情况
    • 专利分析:前十大企业的情况
    • 价格趋势分析

第4章 输液疗法市场:Start-Ups企业方案

  • Start-Ups企业 (前十大企业)的分析
    • 投资额
    • 市场收益额
    • 市场占有率
    • 市场规模·用途分析
    • 创业投资与资金筹措方案

第5章 输液疗法市场:产业的市场进入方案

  • 管理体制:概要
  • 新商务和「企业发展的难易度指标」(Ease of Doing business index)
  • 案例研究:成功的创投公司
  • 客户分析:前十大企业的情况

第6章 输液疗法市场影响要素

  • 市场促进因素
  • 市场阻碍因素·课题
  • 波特的五力分析

第7章 输液疗法市场:策略分析

  • 价值链分析
  • 市场机会分析
  • 产品生命周期
  • 供应商/经销商的市场占有率

第8章 输液疗法市场:各治疗法

  • 简介
  • 人用
    • 维持疗法
    • 输液苏醒

第9章 各输液疗法市场:输液手法

  • 简介
  • 人用
    • 口服输液
    • 皮下输液
    • 静脉内输液
    • 骨髓内输液
  • 动物用
    • 口服输液
    • 皮下输液
    • 腹腔内输液
    • 静脉内输液
    • 骨髓内输液
    • 其他

第10章 输液疗法市场:输液类别

  • 简介
  • 人用
    • 胶体
    • 晶体液
      • 等渗透压
      • 低渗透压
      • 高渗透压
    • 血液·血液制剂
  • 动物用
    • 胶体
      • 天然
      • 合成
    • 晶体液
      • 等渗透压
      • 低渗透压
      • 高渗透压

第11章 输液疗法市场:各用途

  • 简介
  • 人用
    • 麻醉
    • 心肺苏醒 (CPR)
    • 鬱血性心衰竭 (CHF)
    • 输液
    • 高渗食鹽水
    • 其他
  • 动物用
    • 麻醉
    • 贫血症
    • 腹泻
    • 低血容量
    • 心脏疾病
    • 其他

第12章 输液疗法市场:各地区

  • 简介
  • 北美市场
    • 美国,加拿大,墨西哥等
  • 南美市场
    • 巴西,委内瑞拉,阿根廷,厄瓜多,秘鲁,哥伦比亚,哥斯大黎加等
  • 欧洲市场
    • 法国,丹麦,德国,西班牙,比利时,英国,义大利,荷兰等
  • 亚太地区市场
    • 中国,印度,日本,韩国,澳洲·纽西兰,台灣,马来西亚等
  • 其他的国家的市场 (RoW:中东·非洲)

第13章 输液疗法市场:市场变化的方向性

  • 新产品的销售
  • 企业合并·收购 (M&A),事业合作·联盟,合资企业 (JV)

第14章 输液疗法市场:各产业/各领域的竞争情形

  • 市场占有率分析
    • 各国市场占有率:大企业的情况
    • 各地区的市场占有率:前十大企业的情况
    • 各用途的市场占有率:前十大企业的情况
    • 各产品/产品类型的市场占有率:前十大企业的情况
    • 全球整体的市场占有率:前十大企业的情况
    • 各种对企业而言的最佳业务实践

第15章 主要企业一览:各国

第16章 企业分析

  • 市场占有率,企业收益额,主要产品,企业合并·收购 (M&A),近几年趋势
  • Baxter International, Inc. (美国)
  • B. Braun Melsungen AG (德国)
  • Fresenius Kabi AG (德国)
  • Dechra Veterinary Products, LLC (美国)
  • D.J. Laboratories Pvt. Ltd (印度)
  • Animalcare Ltd. (英国)
  • ICU Medical (美国)
  • 其他

第17章 附录

第18章 分析方法

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: HCR 1264

Fluid Therapy Market Overview

Fluid therapy is involves infusing crystalloid solutions into patients who are hypovolemic, or in cases of dehydration to replace ongoing fluid losses and meet the fluid requirements of patients who cannot take fluids orally. The Fluid Therapy market has been segmented on the basis of therapy type, routes of fluid administration, types of fluids, by application, and by geographic regions.

Different types of fluids such as colloidal solutions, crystalloid solutions, and blood products are used during fluid therapy. Administration of these fluids is done by using different routes such as oral, subcutaneous, intravenous, intraosseous, and so on. The fluid therapy market generated revenue of $7,297m in 2017 and is estimated to exceed $10,559m by 2023, growing at an estimated CAGR of 6.4%.

Fluid Therapy Market Outlook

The global Fluid Therapy market has been witnessing a brisk growth in the recent years owing to increased incidences of chronic diseases related to nephrology, gastrointestinal tract, heart failures, cancer and diabetes. Fluid therapy is used to treat disorders such as sepsis, colic, hypovolemia and shock. Innovative products and services can help physicians and doctors protect both humans and animals from such diseases. The human segment accounted for 78% of the total market share in 2017.

Colloids and crystalloids are the types of fluids uses in fluid therapy to maintain or restore the vascular volume and tissue perfusion in humans and animals. In humans, at times, blood and blood products are also intravenously administered to restore circulation to vital organs following loss of intravascular volume due to bleeding, plasma loss, and so on. North America dominated the Fluid Therapy Market with 33% of the overall market revenue in 2017. The Asia-Pacific region forecast to be the fastest growing market for fluid therapy. The region's market is estimated to grow at a CAGR of 7.4% during the forecast period 2018-2023.

Fluid Therapy Market Growth Drivers

Increased awareness among people about fitness and health issues and their urge to take preventive steps to avoid chronic diseases are the major factors driving the market for fluid therapy. The rise in demand for maintenance therapy using colloids and crystalloids is also boosting the market for fluid therapy. Due to rapid urbanization, and sedentary lifestyle of people, there has been an exponential rise in chronic diseases such as cancer, diabetes, CVDs, arthritis, COPD, and diabetes. Thus, the demand for intravenous fluid therapy is increasing rapidly.

Fluid Therapy Market Challenges

Plastic contaminants have been found in blood products stored for long periods in bags. Frequent use of such solvable plastics in high doses can harm patients and research laboratory animals. Plastic bags can leach toxic chemicals into patients' veins. So, this is a major constraint for the fluid therapy market.

Strigent regulations regarding the approvals of medical devices use in fluid therapy and high costs associated with the treatment are hindering the growth of fluid therapy market

Fluid Therapy Market Research Scope

The base year of the study is 2017, with forecast done up to 2023. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the fluid therapy market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of fluid therapy and fluids, and their specific applications.

Fluid Therapy Market Report: Industry Coverage

Fluid Therapy Market - By Therapy: Maintenance Therapy and Fluid Resuscitation

Fluid Therapy Market - By Routes of Fluid Administration: Oral, Subcutaneous, Intravenous, Intraosseous, Intraperitoneal and Others

Fluid Therapy Market - By Types of Fluids: Colloids, Crystalloids, Blood & Blood Products and Others

Fluid Therapy Market - By Application: Human and Animals

The Fluid Therapy market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

North America: The U.S., Canada, Mexico

South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica

Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark

APAC: China, Japan, Australia & New Zealand, South Korea, India, Taiwan, Malaysia

Middle East and Africa: Israel, South Africa, Saudi Arabia

Fluid Therapy Market Key Players

Some of the key players mentioned in this market research report include Baxter International, Inc. (the U.S.), B. Braun Melsungen AG (Germany) Fresenius Kabi AG (Germany), Dechra Veterinary Products, LLC (the U.S.), D.J. Laboratories Pvt. Ltd (India), Animalcare Ltd. (the U.K.), and ICU Medical (the U.S.).

Fluid Therapy Market Trends

Patient's fast recovery owing to fluid therapy is providing opportunities to the market players to manufacture innovative products, which drives the market growth.

The global market for fluid therapy is well established and its growth can be accredited to the growing health awareness and an increase in chronic diseases in the past few years.

North America dominated the fluid therapy market with a share of 33% of the total market value in 2017. The market in North America was valued at $2,386 m in 2017 and is estimated to reach $3,516m by 2023.

Innovative fluid therapy products are more helpful to nurses in case of treatment, thus providing manufacturers an opportunity to attract end users and enhance their market share

1. Fluid Therapy Market - Overview

  • 1.1. Definitions and Scope

2. Fluid Therapy Market - Executive Summary

  • 2.1. Market Revenue, Market Size and Key Trends by Company
  • 2.2. Key Trends by type of Application
  • 2.3. Key Trends segmented by Geography

3. Fluid Therapy Market - Market Landscape

  • 3.1. Comparative Analysis
    • 3.1.1. Product Benchmarking - Top 10 companies
    • 3.1.2. Top 5 Financials Analysis
    • 3.1.3. Market Value split by Top 10 companies
    • 3.1.4. Patent Analysis - Top 10 companies
    • 3.1.5. Pricing Analysis

4. Fluid Therapy Market - Market Forces

  • 4.1. Drivers
  • 4.2. Constraints & Challenges
  • 4.3. Porters five force model
    • 4.3.1. Bargaining power of suppliers
    • 4.3.2. Bargaining powers of customers
    • 4.3.3. Threat of new entrants
    • 4.3.4. Rivalry among existing players
    • 4.3.5. Threat of substitutes

5. Fluid Therapy Market - Strategic Analysis

  • 5.1. Value chain analysis
  • 5.2. Opportunities analysis
  • 5.3. Product/Market Life Cycle Analysis
  • 5.4. Suppliers and distributors Market Share

6. Fluid Therapy Market - By Therapy

  • 6.1. Introduction
  • 6.2. Human
    • 6.2.1. Maintenance Therapy
    • 6.2.2. Fluid Resuscitation

7. Fluid Therapy Market - By Route of Fluid Administration

  • 7.1. Introduction
  • 7.2. Human
    • 7.2.1. Oral
    • 7.2.2. Subcutaneous
    • 7.2.3. Intravenous
    • 7.2.4. Intraosseous
    • 7.2.5. Others
  • 7.3. Animal
    • 7.3.1. Oral
    • 7.3.2. Subcutaneous
    • 7.3.3. Intraperitoneal
    • 7.3.4. Intravenous
    • 7.3.5. Intraosseous
    • 7.3.6. Others

8. Fluid Therapy Market - By Type of Fluid

  • 8.1. Introduction
  • 8.2. Human
    • 8.2.1. Colloids
    • 8.2.2. Crystalloids
      • 8.2.2.1. Isotonic
      • 8.2.2.2. Hypotonic
      • 8.2.2.3. Hypertonic
    • 8.2.3. Blood & Blood Products
  • 8.3. Animal
    • 8.3.1. Colloids
      • 8.3.1.1. Natural
      • 8.3.1.2. Synthetic
    • 8.3.2. Crystalloids
      • 8.3.2.1. Isotonic
      • 8.3.2.2. Hypotonic
      • 8.3.2.3. Hypertonic

9. Fluid Therapy Market - By Application

  • 9.1. Introduction
  • 9.2. Human
    • 9.2.1. Anesthesia
    • 9.2.2. Cardiopulmonary Resuscitation (CPR)
    • 9.2.3. Congestive Heart Failure (CHF)
    • 9.2.4. Fluids and Transfusions
    • 9.2.5. Hypertonic Saline
    • 9.2.6. Others
  • 9.3. Animal
    • 9.3.1. Anesthesia
    • 9.3.2. Anemia
    • 9.3.3. Diarrhea
    • 9.3.4. Hypovolemia
    • 9.3.5. Cardiac Disease
    • 9.3.6. Others

10. Fluid Therapy Market - By Geography

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. U.S.
    • 10.2.2. Canada
    • 10.2.3. Mexico
  • 10.3. South America
    • 10.3.1. Brazil
    • 10.3.2. Venezuela
    • 10.3.3. Argentina
    • 10.3.4. Ecuador
    • 10.3.5. Peru
    • 10.3.6. Colombia
    • 10.3.7. Costa Rica
    • 10.3.8. Rest of South America
  • 10.4. Europe
    • 10.4.1. France
    • 10.4.2. Denmark
    • 10.4.3. Germany
    • 10.4.4. Spain
    • 10.4.5. Belgium
    • 10.4.6. U.K.
    • 10.4.7. Italy
    • 10.4.8. The Netherlands
    • 10.4.9. Rest of Europe
  • 10.5. Asia Pacific
    • 10.5.1. China
    • 10.5.2. India
    • 10.5.3. Japan
    • 10.5.4. South Korea
    • 10.5.5. Australia & New Zealand
    • 10.5.6. Taiwan
    • 10.5.7. Malaysia
    • 10.5.8. Rest of Asia-Pacific
  • 10.6. Rest of the World
    • 10.6.1. Middle East
    • 10.6.2. Africa

11. Fluid Therapy Market - Market Entropy

  • 11.1. New product launches
  • 11.2. M&A, Collaboration, Partnerships, & JVs

12. Fluid Therapy Market Company Analysis

  • 12.1. Market Share, Company Revenue, Products, M&A, Developments
  • 12.2. Baxter International, Inc. (the U.S.)
  • 12.3. B. Braun Melsungen AG (Germany)
  • 12.4. Fresenius Kabi AG (Germany)
  • 12.5. Dechra Veterinary Products, LLC (the U.S.)
  • 12.6. D.J. Laboratories Pvt. Ltd (India)
  • 12.7. Animalcare Ltd. (the U.K.)
  • 12.8. ICU Medical (the U.S.)
  • 12.9. Company 8
  • 12.10. Company 9
  • 12.11. Company 10 and more

"*Financials would be provided on a best efforts basis for private companies"

13. Fluid Therapy Market -Appendix

  • 13.1. Abbreviations
  • 13.2. Sources